Quercetin: A flavonol with multifaceted therapeutic applications?

Hertog, 1993, Intake of potentially anticarcinogenic flavonoids and their determinants in adults in The Netherlands, Nutr. Cancer, 20, 21, 10.1080/01635589309514267

Formica, 1995, Review of the biology of quercetin and related bioflavonoids, Food Chem. Toxicol., 33, 1061, 10.1016/0278-6915(95)00077-1

Beecher, 1999, Analysis of tea polyphenols, Proc. Soc. Exp. Biol. Med., 220, 267, 10.3181/00379727-220-44377A

Linseisen, 1997, Flavonoidzufuhr erwachsener in einem bayrischen teilkollektiv der nationalen verzehrsstudie, Z. Ernahrungswiss., 36, 403, 10.1007/BF01617836

Böhm, 1998, Flavonols, flavone and anthocyanins as natural antioxidants of food and their possible role in the prevention of chronic diseases, Z. Ernahrungswiss., 37, 147, 10.1007/PL00007376

Harwood, 2007, A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties, Food Chem. Toxicol., 45, 2179, 10.1016/j.fct.2007.05.015

Bors, 1994, Flavonoid antioxidants: rate constants for reactions with oxygen radicals, Methods Enzymol., 234, 420, 10.1016/0076-6879(94)34112-5

Galati, 2001, Peroxidative metabolism of apigenin and naringenin versus luteolin and quercetin: glutathione oxidation and conjugation, Free Radic. Biol. Med., 30, 370, 10.1016/S0891-5849(00)00481-0

Awad, 2002, The regioselectivity of glutathione adduct formation with flavonoid quinone/quinone methides is pH-dependent, Chem. Res. Toxicol., 15, 343, 10.1021/tx010132l

Vrijsen, 1990, Metabolic activation of quercetin mutagenicity, Mutat. Res., 232, 243, 10.1016/0027-5107(90)90130-V

Jurado, 1991, Study on the mutagenic activity of 13 bioflavonoids with the Salmonella Ara test, Mutagenesis, 6, 289, 10.1093/mutage/6.4.289

Rueff, 1995, Structural requirements for mutagenicity of flavonoids upon nitrosation. A structure-activity study, Mutagenesis, 10, 325, 10.1093/mutage/10.4.325

Silva, 2000, Chemical features offlavonols affecting their genotoxicity. Potential implications in their use as therapeutical agents, Chem. Biol. Interact., 124, 29, 10.1016/S0009-2797(99)00139-8

de Boer, 2005, Tissue distribution of quercetin in rats and pigs, J. Nutr., 135, 1718, 10.1093/jn/135.7.1718

Chen, 2005, Pharmacokinetics and modeling of quercetin and metabolites, Pharm. Res., 22, 892, 10.1007/s11095-005-4584-1

Graefe, 2001, Pharmacokinetics and bioavailability of quercetin glycosides in humans, J. Clin. Pharmacol., 41, 492, 10.1177/00912700122010366

Kawabata, 2015, Quercetin and related polyphenols: new insights and implications for their bioactivity and bioavailability, Food Funct., 6, 1399, 10.1039/C4FO01178C

Fischer, 1997, Induction of zygotic polyembryos in wheat: influence of auxin polar transport, Plant Cell, 9, 1767, 10.1105/tpc.9.10.1767

Shiro, 1938, Research for vitamin P, J. Biochem., 29, 487

de Souza, 2004, Antioxidant properties of complexes of flavonoids with metal ions, Redox Rep., 9, 97, 10.1179/135100004225003897

Heijnen, 2002, Protection of flavonoids against lipid peroxidation: the structure activity relationship revisited, Free Radic. Res., 36, 575, 10.1080/10715760290025951

Hanasaki, 1994, The correlation between active oxygens scavenging and antioxidative effects of flavonoids, Free Radic. Biol. Med., 16, 845, 10.1016/0891-5849(94)90202-X

Cushnie, 2005, Antimicrobial activity of flavonoids, Int. J. Antimicrob. Agents, 26, 343, 10.1016/j.ijantimicag.2005.09.002

van Acker, 1995, Flavonoids as scavengers of nitric oxide radical, Biochem. Biophys. Res. Commun., 214, 755, 10.1006/bbrc.1995.2350

Haenen, 1999, Nitric oxide radical scavenging of flavonoids, Methods Enzymol., 301, 490, 10.1016/S0076-6879(99)01112-X

Haenen, 1997, Peroxynitrite scavenging byflavonoids, Biochem. Biophys. Res. Commun., 236, 591, 10.1006/bbrc.1997.7016

Heijnen, 2001, Flavonoids as peroxynitrite scavengers: the role of the hydroxyl groups, Toxicol. in Vitro, 15, 3, 10.1016/S0887-2333(00)00053-9

Hollman, 1997, Absorption, metabolism and health effects of dietary flavonoids in man, Biomed. Pharmacother., 51, 305, 10.1016/S0753-3322(97)88045-6

Sakanashi, 2008, Possible use of quercetin, an antioxidant, for protection of cells suffering from overload of intracellular Ca2+: a model experiment, Life Sci., 83, 164, 10.1016/j.lfs.2008.05.009

Kahl, 1986, Methodology for studying antioxidant activity and mechanisms of action of antioxidants, Food Chem. Toxicol., 24, 1007, 10.1016/0278-6915(86)90281-4

Balazs, 1994, Evidence of an oxidative challenge in the Alzheimer's brain, Neurochem. Res., 19, 1131, 10.1007/BF00965146

Ansari, 2009, Protective effect of quercetin in primary neurons against Aβ (1–42): relevance to Alzheimer's disease, J. Nutr. Biochem., 20, 269, 10.1016/j.jnutbio.2008.03.002

Shoskes, 1999, Quercetin in men with category III chronic prostatitis: a preliminary prospective, double blinded, placebo controlled trial, Urology, 54, 960, 10.1016/S0090-4295(99)00358-1

Begum, 2002, Protective effect of quercetin against cigarette tar extract induced impairment of erythrocyte deformability, J. Nutr. Biochem., 13, 265, 10.1016/S0955-2863(01)00219-4

McAnulty, 2008, Chronic quercetin ingestion and exercise-induced oxidative damage and inflammation, Appl. Physiol. Nutr. Metab., 33, 254, 10.1139/H07-177

Arts, 2004, A new approach to assess the total antioxidant capacity using the TEAC assay, Food Chem., 88, 567, 10.1016/j.foodchem.2004.02.008

Nabavi, 2012, In vivo protective effects of quercetin against sodium fluoride-induced oxidative stress in the hepatic tissue, Food Chem., 132, 931, 10.1016/j.foodchem.2011.11.070

Nabavi, 2012, Ameliorative effects of quercetin on sodium fluoride-induced oxidative stress in rat's kidney, Ren. Fail., 34,, 901, 10.3109/0886022X.2012.687347

Nabavi, 2012, Protective effect of quercetin against sodium fluoride induced oxidative stress in rat's heart, Food Funct., 3, 437, 10.1039/c2fo10264a

Boots, 2007, The quercetin paradox, FEBS Lett., 222, 89

Ames, 1973, An improved bacterial test system for the detection and classification of mutagens and carcinogens, Proc. Natl. Acad. Sci. U. S. A., 70, 782, 10.1073/pnas.70.3.782

Okamoto, 2005, Safety of quercetin for clinical application (review), Int. J. Mol. Med., 16, 275

Utesch, 2008, Evaluation of the potential in vivo genotoxicity of quercetin, Mutat. Res., 654, 38, 10.1016/j.mrgentox.2008.04.008

Bast, 2002, The toxicity of antioxidants and their metabolites, Environ. Toxicol. Pharmacol., 11, 251, 10.1016/S1382-6689(01)00118-1

Hollman, 1999, Dietary flavonoids: intake, health effects and bioavailability, Food Chem. Toxicol., 37, 937, 10.1016/S0278-6915(99)00079-4

Skibola, 2000, Potential health impacts of excessive flavonoid intake, Free Radic. Biol. Med., 29, 375, 10.1016/S0891-5849(00)00304-X

Boots, 2002, Oxidative damage shifts from lipid peroxidation to thiol arylation by catechol-containing antioxidants, Biochim. Biophys. Acta, 1583, 279, 10.1016/S1388-1981(02)00247-0

Boots, 2003, Oxidized quercetin reacts with thiols rather than with ascorbate: implication for quercetin supplementation, Biochem. Biophys. Res. Commun., 308, 560, 10.1016/S0006-291X(03)01438-4

Mendoza, 2011, Quercetin as a systemic chemopreventative agent: structural and functional mechanisms, Mini-Rev. Med. Chem., 11, 1216

Brown, 1980, A review of the genetic effects of naturally occurring flavonoids, anthraquinones and related compounds, Mutat. Res., 75, 243, 10.1016/0165-1110(80)90029-9

Mitchell, 2007, Ten-year comparison of the influence of organic and conventional crop management practices on the content of flavonoids in tomatoes, J. Agric. Food Chem., 55, 6154, 10.1021/jf070344+

Day, A.J.; Williamson, G. Human metabolism of dietary quercetin glycosides. In: Plant Polyphenols 2: Chemistry, Biology, Pharmacology, Ecology. Basic Life Sciences, Gross, G.G.; Hemingway, R.W.; Yoshida, T. (Eds.); Kluwer Academic/Plenum Publishers: New York, 1999; 66, pp. 415–434.

Harnly, 2006, Flavonoid content of US fruits, vegetables, and nuts, J. Agric. Food Chem., 54, 9966, 10.1021/jf061478a

Hertog, 1993, Content of potentially anticarcinogenic flavonoids of tea infusions, wines, and fruit juices, J. Agric. Food Chem., 41, 1242, 10.1021/jf00032a015

Sampson, 2002, Flavonol and flavone intakes in US health professionals, J. Am. Diet. Assoc., 102, 1414, 10.1016/S0002-8223(02)90314-7

Fang, 1986, Flavonoids from Ageratina calophylla, Phytochemistry, 25, 2684, 10.1016/S0031-9422(00)84545-8

Zeng, 2010, Flavonoids from the red alga Acanthophora spicifera, Chin. J. Chem., 19, 1097, 10.1002/cjoc.20010191116

Del Santo, 2013, The plasticity of the grapevine berry transcriptome, MetaboLights, 39

Kühnau, 1976, The flavonoids: a class of semi-essential food components: their role in human nutrition, World Rev. Nutr. Diet., 24, 117, 10.1159/000399407

Jones, 1982, Quercetin, flavonoids and the life-span of mice, Exp. Gerontol., 17, 213, 10.1016/0531-5565(82)90027-4

Rimm, 1996, Relation between intake of flavonoids and risk for coronary heart disease in male health professionals, Ann. Intern. Med., 125, 384, 10.7326/0003-4819-125-5-199609010-00005

Hertog, 1995, Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study, Arch. Intern. Med., 155, 381, 10.1001/archinte.1995.00430040053006

Knekt, 1997, Dietary intake of flavonoids and the risk of lung cancer and other malignant neoplasms, Am. J. Epidemiol., 146, 223, 10.1093/oxfordjournals.aje.a009257

Kimira, 1998, Japanese intake of flavonoids and isoflavonoids from foods, J. Epidemiol., 8, 168, 10.2188/jea.8.168

Johannot, 2006, Age-related variations in flavonoid intake and sources in the Australian population, Public Health Nutr., 9, 1045, 10.1017/PHN2006971

Lin, 2006, Flavonoid intake and colorectal cancer risk in men and women, Am. J. Epidemiol., 164, 644, 10.1093/aje/kwj296

Jackson, 1997, The assessment of bioavailability of micronutrients: introduction, Eur. J. Clin. Nutr., 51, S1

Toutain, 2004, Bioavailability and its assessment, J. Vet. Pharmacol. Ther., 27, 455, 10.1111/j.1365-2885.2004.00604.x

Scholz, 2007, Interactions affecting the bioavailability of dietary polyphenols in vivo, Int. J. Vitam. Nutr. Res., 77, 224, 10.1024/0300-9831.77.3.224

Gugler, 1975, Disposition of quercetin in man after single oral and intravenous doses, Eur. J. Clin. Pharmacol., 9, 229, 10.1007/BF00614022

Walle, 2001, Carbon dioxide is the major metabolite of quercetin in humans, J. Nutr., 131, 2648, 10.1093/jn/131.10.2648

Zhang, 2010, Dietary flavonol and flavones intakes and their major food sources in Chinese adults, Nutr. Cancer, 62, 1120, 10.1080/01635581.2010.513800

Boots, 2008, Health effects of quercetin: from antioxidant to nutraceutical, Eur. J. Pharmacol., 585, 325, 10.1016/j.ejphar.2008.03.008

Manach, 2005, Bioavailability and bioefficacy of polyphenols in humans. Review of 97 bioavailability studies, Am. J. Clin. Nutr., 81, 230S, 10.1093/ajcn/81.1.230S

Tamura, 1980, Fecalase: a model for activation of dietary glycosides to mutagens by intestinal flora, Proc. Natl. Acad. Sci. U. S. A., 77, 4961, 10.1073/pnas.77.8.4961

Manach, 1998, Quercetin is recovered in human plasma as conjugated derivatives which retain antioxidant properties, FEBS Lett., 426, 331, 10.1016/S0014-5793(98)00367-6

Moon, 2000, Accumulation of quercetin conjugates in blood plasma after the short-term ingestion of onion by women, Am. J. Physiol. Regul. Integr. Comp. Physiol., 279, R461, 10.1152/ajpregu.2000.279.2.R461

Moon, 2001, Identification of quercetin 3-O-β-d-glucuronide an antioxidative metabolite in rat plasma after oral administration of quercetin, Free Radic. Biol. Med., 30, 1274, 10.1016/S0891-5849(01)00522-6

Manach, 1996, Dietary quercetin is recovered in rat plasma as conjugated derivatives of isorhamnetin and quercetin, Nutr. Biochem., 7, 375, 10.1016/S0955-2863(96)00058-7

da Silva, 1998, Quercetin metabolites inhibit copper ion-induced lipid peroxidation in rat plasma, FEBS Lett., 430, 405, 10.1016/S0014-5793(98)00709-1

Guo, 2015, Endogenous and exogenous mediators of quercetin bioavailability, J. Nutr. Biochem., 26, 201, 10.1016/j.jnutbio.2014.10.008

Hollman, 1996, Absorption and disposition kinetics of the dietary antioxidant quercetin in man, Free Radic. Biol. Med., 21, 703, 10.1016/0891-5849(96)00129-3

Conquer, 1998, Supplementation with quercetin markedly increases plasma quercetin concentration without effect on selected risk factors for heart disease in healthy subjects, J. Nutr., 128, 593, 10.1093/jn/128.3.593

Bischoff, 2008, Quercetin: potentials in the prevention and therapy of disease, Curr. Opin. Clin. Nutr. Metab. Care, 11, 733, 10.1097/MCO.0b013e32831394b8

Crespy, 2002, Quercetin, but not its glycosides, is absorbed from the rat stomach, J. Agric. Food Chem., 50, 618, 10.1021/jf010919h

Crespy, 1999, Part of quercetin absorbed in the small intestine is conjugated and further secreted in the intestinal lumen, Am. J. Physiol., 277, 120

Nait Chabane, 2009, Quercetin and naringenin transport across human intestinal Caco-2 cells, J. Pharm. Pharmacol., 61, 1473, 10.1211/jpp.61.11.0006

Arts, 2004, The type of sugar moiety is a major determinant of the small intestinal uptake and subsequent biliary excretion of dietary quercetin glycosides, Br. J. Nutr., 91, 841, 10.1079/BJN20041123

Nemeth, 2003, Deglycosylation by small intestinal epithelial cell β-glucosidases is a critical step in the absorption and metabolism of dietary flavonoid glycosides in humans, Eur. J. Nutr., 42, 29, 10.1007/s00394-003-0397-3

Day, 2003, Absorption of quercetin-3-glucoside and quercetin-4′-glucoside in the rat small intestine: the role of lactase phlorizin hydrolase and the sodium-dependent glucose transporter, Biochem. Pharmacol., 65, 1199, 10.1016/S0006-2952(03)00039-X

Jaganath, 2006, The relative contribution of the small and large intestine to the absorption and metabolism of rutin in man, Free Radic. Res., 40, 1035, 10.1080/10715760600771400

Kim, 1998, Intestinal bacterial metabolism of flavonoids and its relation to some biological activities, Arch. Pharm. Res., 21, 17, 10.1007/BF03216747

Aura, 2002, Quercetin derivatives are deconjugated and converted to hydroxyphenylacetic acids but not methylated by human fecal flora in vitro, J. Agric. Food Chem., 50, 1725, 10.1021/jf0108056

Del Rio, 2013, Dietary (poly)phenolics in human health: structures, bioavailability, and evidence of protective effects against chronic diseases, Antioxid. Redox Signal., 18, 1818, 10.1089/ars.2012.4581

Omiecinski, 2011, Xenobiotic metabolism, disposition, and regulation by receptors: from biochemical phenomenon to predictors of major toxicities, Toxicol. Sci., 120, 49, 10.1093/toxsci/kfq338

Gradolatto, 2004, Metabolism of apigenin by rat liver phase I and phase ii enzymes and by isolated perfused rat liver, Drug Metab. Dispos., 32, 58, 10.1124/dmd.32.1.58

van der Woude, 2004, Identification of 14 quercetin phase II mono- and mixed conjugates and their formation by rat and human phase II in vitro model systems, Chem. Res. Toxicol., 17, 1520, 10.1021/tx049826v

Graf, 2006, Rat gastrointestinal tissues metabolize quercetin, J. Nutr., 136, 39, 10.1093/jn/136.1.39

Murota, 2013, Influence of fatty acid patterns on the intestinal absorption pathway of quercetin in thoracic lymph duct-cannulated rats, Br. J. Nutr., 109, 2147, 10.1017/S0007114512004564

Sesink, 2005, Breast cancer resistance protein (Bcrp1/Abcg2) limits net intestinal uptake of quercetin in rats by facilitating apical efflux of glucuronides, Mol. Pharmacol., 67, 1999, 10.1124/mol.104.009753

Williamson, 2007, Interaction of positional isomers of quercetin glucuronides with the transporter ABCC2 (cMOAT, MRP2), Drug Metab. Dispos., 35, 1262, 10.1124/dmd.106.014241

Wong, 2012, Carrier-mediated transport of quercetin conjugates: involvement of organic anion transporters and organic anion transporting polypeptides, Biochem. Pharmacol., 84, 564, 10.1016/j.bcp.2012.05.011

O'Leary, 2003, Metabolism of quercetin-7- and quercetin-3-glucuronides by an in vitro hepatic model: the role of human beta glucuronidase, sulfotransferase, catechol-O-methyltransferase and multi-resistant protein 2 (MRP2) in flavonoid metabolism, Biochem. Pharmacol., 65, 479, 10.1016/S0006-2952(02)01510-1

Mullen, 2008, Bioavailability of [2-(14)C]quercetin-4′-glucoside in rats, J. Agric. Food Chem., 56, 12127, 10.1021/jf802754s

Mullen, 2006, Absorption, excretion and metabolite profiling of methyl-, glucuronyl-, glucosyl- and sulpho-conjugates of quercetin in human plasma and urine after ingestion of onions, Br. J. Nutr., 96, 107, 10.1079/BJN20061809

Gross, 1996, The quantitation of metabolites of quercetin flavonols in human urine, Cancer Epidemiol. Biomark. Prev., 5, 711

Bieger, 2008, Tissue distribution of quercetin in pigs after long-term dietary supplementation, J. Nutr., 138, 1417, 10.1093/jn/138.8.1417

Ferry, 1996, Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition, Clin. Cancer Res., 4, 659

Zahedi, 2013, Does quercetin improve cardiovascular risk factors and inflammatory biomarkers in women with type 2 diabetes: a double-blind randomized controlled clinical trial, Int. J. Prev. Med., 4, 777

Dower, 2015, Effects of the pure flavonoids epicatechin and quercetin on vascular function and cardiometabolic health: a randomized, double-blind, placebo-controlled, crossover trial, Am. J. Clin. Nutr., 101, 914, 10.3945/ajcn.114.098590

Dower, 2015, Supplementation of the pure flavonoids epicatechin and quercetin affects some biomarkers of endothelial dysfunction and inflammation in (pre)hypertensive adults: a randomized double-blind, placebo-controlled, crossover trial, J. Nutr., 145, 1459, 10.3945/jn.115.211888

Amirchaghmaghi, 2015, Randomized placebo-controlled double blind clinical trial of quercetin for treatment of oral Lichen planus, J. Dent. Res. Dent. Clin. Dent. Prospects, 9, 23, 10.15171/joddd.2015.005

Packer, 1974, Extension of the lifespan of cultured normal human diploid cells by vitamin E, Proc. Natl. Acad. Sci. U. S. A., 71, 4763, 10.1073/pnas.71.12.4763

Rattan, 1994, Kinetin delays the onset of ageing characteristics in human fibroblasts, Biochem. Biophys. Res. Commun., 201, 665, 10.1006/bbrc.1994.1752

McFarland, 1994, Retardation of the senescence of cultured human diploidfibroblasts by carnosine, Exp. Cell Res., 212, 167, 10.1006/excr.1994.1132

Svendsen, 1994, Testing garlic for possible anti-ageing effects on long-term growth characteristics, morphology and macromolecular synthesis of humanfibroblasts in culture, J. Ethnopharmacol., 43, 125, 10.1016/0378-8741(94)90009-4

Trougakos, 2003, Slowing down cellular ageing in vitro, 65

Chondrogianni, 2010, Anti-ageing and rejuvenating effects of quercetin, Exp. Gerontol., 45, 763, 10.1016/j.exger.2010.07.001

Zhu, 2015, The Achilles' heel of senescent cells: from transcriptome to senolytic drugs, Aging Cell, 1

Kirkland, 2013, Inflammation and cellular senescence: potential contribution to chronic diseases and disabilities with aging, Public Policy Aging Rep., 23, 12, 10.1093/ppar/23.4.12

Kirkland, 2014, Clinical strategies and animal models for developing senolytic agents, Exp. Gerontol., S0531–5565, 291

Shaik, 2006, Role of quercetin (a natural herbal compound) in allergy and inflammation, J. Biol. Regul. Homeost. Agents, 20, 47

Chirumbolo, 2011, Quercetin as a potential anti-allergic drug: which perspectives?, Iran. J. Allergy Asthma Immunol., 10, 139

Pashevin, 2011, Antiatherogenic effect of quercetin is mediated by proteasome inhibition in the aorta and circulating leukocytes, Pharmacol. Rep., 63, 1009, 10.1016/S1734-1140(11)70617-X

Perez-Vizcaino, 2010, Flavonols and cardiovascular disease, Mol. Asp. Med., 31, 478, 10.1016/j.mam.2010.09.002

Larson, 2012, Therapeutic potential of quercetin to decrease blood pressure: review of efficacy and mechanisms, Adv. Nutr., 3, 39, 10.3945/an.111.001271

Yang, 2015, Combination of quercetin and 2-methoxyestradiol enhances inhibition of human prostate cancer lncap and PC-3 cells xenograft tumor growth, PLoS One, 26

Hung, 2015, Quercetin is a potent anti-atherosclerotic compound by activation of SIRT1 signaling under oxLDL stimulation, Mol. Nutr. Food Res., 10.1002/mnfr.201500144

Chirumbolo, 2013, Quercetin in cancer prevention and therapy, Integr. Cancer Ther., 12, 97, 10.1177/1534735412448215

Gorlach, 2015, Polyphenols as mitochondria-targeted anticancer drugs, Cancer Lett., 366, 141, 10.1016/j.canlet.2015.07.004

Dajas, 2012, Life or death: neuroprotective and anticancer effects of quercetin, J. Ethnopharmacol., 143, 383, 10.1016/j.jep.2012.07.005

Russo, 2014, Quercetin: a pleiotropic kinase inhibitor against cancer, Cancer Treat. Res., 159, 185, 10.1007/978-3-642-38007-5_11

Bruning, 2013, Inhibition of mTOR signaling by quercetin in cancer treatment and prevention, Anti Cancer Agents Med. Chem., 13, 1025, 10.2174/18715206113139990114

Maurya, 2015, Modulation of PKC signaling and induction of apoptosis through suppression of reactive oxygen species and tumor necrosis factor receptor 1 (TNFR1): key role of quercetin in cancer prevention, Tumour Biol., 10.1007/s13277-015-3634-5

Sak, 2014, Site-specific anticancer effects of dietary flavonoid quercetin, Nutr. Cancer, 66, 177, 10.1080/01635581.2014.864418

Kim, 1998, Effects of naturally-occurring flavonoids and bioflavonoids on epidermal cyclooxygenase from guinea pigs, Prostaglandins Leukot. Essent. Fat. Acids, 58, 17, 10.1016/S0952-3278(98)90125-9

Lee, 2010, Protective effect of quercetin against arsenite-induced COX-2 expression by targeting PI3K in rat liver epithelial cells, J. Agric. Food Chem., 58, 5815, 10.1021/jf903698s

Yoon, 2012, Anti-inflammatory effect of quercetin in a whole orbital tissue culture of Graves' orbitopathy, Br. J. Ophthalmol., 96, 1117, 10.1136/bjophthalmol-2012-301537

Angeloni, 2012, Quercetin reduces inflammatory responses in LPS-stimulated cardiomyoblasts, Oxidative Med. Cell. Longev., 2012, 837104, 10.1155/2012/837104

Chirumbolo, 2010, The role of quercetin, flavonols and flavones in modulating inflammatory cell function, Inflamm. Allergy Drug Targets, 9, 263, 10.2174/187152810793358741

Ahn, 2008, The anti-obesity effect of quercetin is mediated by the AMPK and MAPK signaling pathways, Biochem. Biophys. Res. Commun., 373, 545, 10.1016/j.bbrc.2008.06.077

Jung, 2013, Quercetin reduces high-fat diet-induced fat accumulation in the liver by regulating lipid metabolism genes, Phytother. Res., 27, 139, 10.1002/ptr.4687

Siriwardhana, 2013, Modulation of adipose tissue inflammation by bioactive food compounds, J. Nutr. Biochem., 24, 613, 10.1016/j.jnutbio.2012.12.013

Kobori, 2014, Dietary quercetin and other polyphenols: attenuation of obesity, 163

Bae, 2009, Effects of antioxidant supplements intervention on the level of plasma inflammatory molecules and disease severity of rheumatoid arthritis patients, J. Am. Coll. Nutr., 28, 56, 10.1080/07315724.2009.10719762

Matsuno, 2009, Effects of an oral administration of glucosamine–chondroitin–quercetin glucoside on the synovial fluid properties in patients with osteoarthritis and rheumatoid arthritis, Biosci. Biotechnol. Biochem., 73, 288, 10.1271/bbb.80418

Knekt, 2002, Flavonoid intake and risk of chronic diseases, Am. J. Clin. Nutr., 76, 560, 10.1093/ajcn/76.3.560

Hirano, 2009, Preventative effect of a flavonoid, enzymatically modified isoquercitrin on ocular symptoms of Japanese cedar pollinosis, Allergol. Int., 58, 373, 10.2332/allergolint.08-OA-0070

Kawai, 2009, Effect of enzymatically modified isoquercitrin, a flavonoid, on symptoms of Japanese cedar pollinosis: a randomized double-blind placebo controlled trial, Int. Arch. Allergy Immunol., 149, 359, 10.1159/000205582

Jeong, 2012, Quercetin ameliorates hyperglycemia and dyslipidemia and improves antioxidant status in type 2 diabetic db/db mice, Nutr. Res. Pract., 6, 201, 10.4162/nrp.2012.6.3.201

Lai, 2012, Quercetin ameliorates diabetic nephropathy by reducing the expressions of transforming growth factor-β1 and connective tissue growth factor in streptozotocin-induced diabetic rats, Ren. Fail., 34, 83, 10.3109/0886022X.2011.623564

Chaudry, 1983, Inhibition of human lens aldose reductase by flavonoids, sulindac, and indomethacin, Biochem. Pharmacol., 32, 1995, 10.1016/0006-2952(83)90417-3

Varma, 1975, Flavonoids as inhibitors of lens aldose reductase, Science, 188, 1215, 10.1126/science.1145193

Varma, 1977, Diabetic cataracts and flavonoids, Science, 195, 205, 10.1126/science.401544

Valensia, 2005, A multicenter, double-blind, safety study of QR-333 for the treatment of symptomatic diabetic peripheral neuropathy: a preliminary report, J. Diabetes Complicat., 19, 247, 10.1016/j.jdiacomp.2005.05.011

Eid, 2015, The molecular basis of the antidiabetic action of quercetin in cultured skeletal muscle cells and hepatocytes, Pharmacogn. Mag., 11, 74, 10.4103/0973-1296.149708

Kressler, 2011, Quercetin and endurance exercise capacity: a systematic review and meta-analysis, Med. Sci. Sports Exerc., 43, 2396, 10.1249/MSS.0b013e31822495a7

Alarcón de la Lastra, 1994, Antiulcer and gastroprotective effects of quercetin: a gross and histologic study, Pharmacology, 48, 56, 10.1159/000139162

Mizui, 1987, Effect of antiperoxidative drugs on gastric damage induced by ethanol in rats, Life Sci., 41, 755, 10.1016/0024-3205(87)90456-5

Rao, 2008, Effect of quercetin, flavonoids and alpha-tocopherol, an antioxidant vitamin, on experimental reflux oesophagitis in rats, Eur. J. Pharmacol., 589, 233, 10.1016/j.ejphar.2008.04.062

Wu, 2015, Protective effects of quercetin against chronic mixed reflux esophagitis in rats by inhibiting the nuclear factor-κB p65 and interleukin-8 signaling pathways, J. Dig. Dis., 16, 319, 10.1111/1751-2980.12249

Shin, 2005, In vitro inhibitory effect of flavonoids on growth, infection and vacuolation of Helicobacter pylori, Planta Med., 71, 197, 10.1055/s-2005-837816

González-Segovia, 2008, Effect of the flavonoid quercetin on inflammation and lipid peroxidation induced by Helicobacter pylori n gastric mucosa of guinea pig, J. Gastroenterol., 43, 441, 10.1007/s00535-008-2184-7

Hamdy, 2010, Management of aphthous ulceration with topical quercetin: a randomized clinical trial, J. Contemp. Dent. Pract., 11, E009, 10.5005/jcdp-11-4-9

Hu, 2015, Quercetin protects gastric epithelial cell from oxidative damage in vitro and in vivo, Eur. J. Pharmacol., 754, 115, 10.1016/j.ejphar.2015.02.007

Siegel, 2014, Cancer statistics, 2014, CA Cancer J. Clin., 64, 9, 10.3322/caac.21208

Noori-Daloii, 2011, Multifaceted preventive effects of single agent quercetin on a human prostate adenocarcinoma cell line (PC-3): implications for nutritional transcriptomics and multi-target therapy, Med. Oncol., 28, 1395, 10.1007/s12032-010-9603-3

Aalinkeel, 1773, The dietary bioflavonoid, quercetin, selectively induces apoptosis of prostate cancer cells by down-regulating the expression of heat shock protein 90, Prostate, 2008, 68

Young, 2010, Suppression of the androgen receptor function by quercetin through protein–protein interactions of Sp1, c-Jun, and the androgen receptor in human prostate cancer cells, Mol. Cell. Biochem., 339, 253, 10.1007/s11010-010-0388-7

Yang, 2015, Combination of quercetin and 2-methoxyestradiol enhances inhibition of human prostate cancer LNCaP and PC-3 cells xenograft tumor growth, PLoS One, 10

Yang, 2015, Quercetin in prostate cancer: chemotherapeutic and chemopreventive effects, mechanisms and clinical application potential (review), Oncol. Rep., 33, 2659, 10.3892/or.2015.3886

Kaul, 1985, Antiviral effect of flavonoids on human viruses, J. Med. Virol., 15, 71, 10.1002/jmv.1890150110

Gonzalez, 1756, The heat shock protein inhibitor quercetin attenuates hepatitis C virus production, Hepatology, 2009, 50

Nieman, 2007, Quercetin reduces illness but not immune perturbations after intensive exercise, Med. Sci. Sports Exerc., 39, 1561, 10.1249/mss.0b013e318076b566

Henson, 2008, Post-160-km race illness rates and decreases in granulocyte respiratory burst and salivary IgA output are not countered by quercetin ingestion, Int. J. Sports Med., 29, 856, 10.1055/s-2007-989424

Betts, 2015, In vitro activity of epigallocatechin gallate and quercetin alone and in combination versus clinical isolates of methicillin-resistant Staphylococcus aureus, J. Nat. Prod., 10.1021/acs.jnatprod.5b00471

Anjaneyulu, 2003, Antidepressant activity of quercetin, a bioflavonoid, in streptozotocin-induced diabetic mice, J. Med. Food, 6, 391, 10.1089/109662003772519976

Bhutada, 2010, Reversal by quercetin of corticotrophin releasing factor induced anxiety- and depression-like effect in mice, Prog. Neuro-Psychopharmacol. Biol. Psychiatry, 34, 955, 10.1016/j.pnpbp.2010.04.025

Priprem, 2008, Anxiety and cognitive effects of quercetin liposomes in rats, Nanomedicine, 4, 70, 10.1016/j.nano.2007.12.001

Adewole, 2006, Protective effect of quercetin on the morphology of pancreatic beta-cells of streptozotocintreated diabetic rats, Afr. J. Tradit. Complement. Altern. Med., 4, 64

Holzmann, 2015, Antidepressant-like effect of quercetin in bulbectomized mice and involvement of the antioxidant defenses, and the glutamatergic and oxidonitrergic pathways, Pharmacol. Biochem. Behav., 136, 55, 10.1016/j.pbb.2015.07.003

Joshi, 2005, Protective effect of quercetin on alcohol abstinence-induced anxiety and convulsions, J. Med. Food, 8, 392, 10.1089/jmf.2005.8.392

Dixon Clarke, 2011, Dietary inhibitors of monoamine oxidase A, J. Neural Transm., 118, 1031, 10.1007/s00702-010-0537-x

Kawabata, 2010, Suppressive effect of quercetin on acute stress-induced hypothalamic-pituitary adrenal axis response in Wistar rats, J. Nutr. Biochem., 21, 374, 10.1016/j.jnutbio.2009.01.008

Chander, 2014, Quercetin mitigates lead acetate-induced behavioral and histological alterations via suppression of oxidative stress, Hsp-70, Bak and upregulation of Bcl-2, Food Chem. Toxicol., 68, 297, 10.1016/j.fct.2014.02.012

Abdalla, 2014, Quercetin protects the impairment of memory and anxiogenic-like behavior in rats exposed to cadmium: possible involvement of the acetylcholinesterase and Na+,K+-ATPase activities, Physiol. Behav., 135, 152, 10.1016/j.physbeh.2014.06.008

Pal, 2006, MDR- and CYP3A4-mediated drug-herbal interactions, Life Sci., 78, 2131, 10.1016/j.lfs.2005.12.010

Choi, 2011, Effects of quercetin on the bioavailability of doxorubicin in rats: role of CYP3A4 and P-gp inhibition by quercetin, Arch. Pharm. Res., 34, 607, 10.1007/s12272-011-0411-x

Chen, 2009, Simultaneous action of the flavonoid quercetin on cytochrome P450 (CYP) 1A2, CYP2A6, N-acetyltransferase and xanthine oxidase activity in healthy volunteers, Clin. Exp. Pharmacol. Physiol., 36, 828, 10.1111/j.1440-1681.2009.05158.x

Kim, 2009, Short-term effect of quercetin on the pharmacokinetics of fexofenadine, a substrate of P-glycoprotein, in healthy volunteers, Eur. J. Clin. Pharmacol., 65, 609, 10.1007/s00228-009-0627-6

Wang, 2004, Lethal quercetin–digoxin interaction in pigs, Life Sci., 74, 1191, 10.1016/j.lfs.2003.06.044

Chan, 2009, Effect of rutin on warfarin anticoagulation and pharmacokinetics of warfarin enantiomers in rats, J. Pharm. Pharmacol., 61, 451, 10.1211/jpp.61.04.0006

Kale, 2010, Studies on the effects of oral administration of nutrient mixture, quercetin and red onions on the bioavailability of epigallocatechin gallate from green tea extract, Phytother. Res., 24, S48, 10.1002/ptr.2899

Moon, 2007, Pharmacokinetics and bioavailability of the bioflavonoid biochanin A: effects of quercetin and EGCG on biochanin A disposition in rats, Mol. Pharm., 4, 865, 10.1021/mp7000928

Naidu, 2003, Possible mechanisms of action in quercetin reversal of morphine tolerance and dependence, Addict. Biol., 8, 327, 10.1080/13556210310001602248

Chen, 2010, Quercetin: a potential drug to reverse multidrug resistance, Life Sci., 87, 333, 10.1016/j.lfs.2010.07.004

Morino, 1982, Carcinogenicity test of quercetin and rutin in golden hamsters by oral administration, Carcinogenesis, 3, 93, 10.1093/carcin/3.1.93

Pérez-Pastén, 2010, Quercetin and naringenin reduce abnormal development of mouse embryos produced by hydroxyurea, J. Pharm. Pharmacol., 62, 1003, 10.1111/j.2042-7158.2010.01118.x

Vanhees, 2011, Prenatal exposure to flavonoids: implication for cancer risk, Toxicol. Sci., 120, 59, 10.1093/toxsci/kfq388

Cantero, 2006, Topoisomerase II inhibition and high yield of endoreduplication induced by the flavonoids luteolin and quercetin, Mutagenesis, 21, 321, 10.1093/mutage/gel033

Sudan, 2014, Quercetin-3-O-glucoside induces human DNA topoisomerase II inhibition, cell cycle arrest and apoptosis in hepatocellular carcinoma cells, Anticancer Res., 34, 1691

Sudan, 2015, Antiproliferative activity of long chain acylated esters of quercetin-3-O-glucoside in hepatocellular carcinoma HepG2 cells, Exp. Biol. Med. (Maywood), 10.1177/1535370215570828

Hossion, 2011, Quercetin diacylglycoside analogues showing dual inhibition of DNA gyrase and topoisomerase IV as novel antibacterial agents, J. Med. Chem., 54, 3686, 10.1021/jm200010x

Miles, 2014, Molecular and physiological actions of quercetin: need for clinical trials to assess its benefits in human disease, Nutr. Rev., 72, 720, 10.1111/nure.12152

Phenol-Explorer, Database on polyphenol content in food, Food composition; http://phenol-explorer.eu/contents/polyphenol/330 (Accessed September 16, 2015).

U.S. National Library of Medicine, Open Chemistry Database, http://pubchem.ncbi.nlm.nih.gov/compound/5280343#section=Top (Accessed September 16, 2015).

USDA Database for the Flavonoid Content of Selected Foods, Release 3.1, December 2013, Slightly revised, May 2014, prepared by Bhagwat, S.; Haytowitz, D.B.; Holden, J.M. (ret.), http://www.ars.usda.gov/News/docs.htm?docid=6231 (Accessed September 16, 2015).

Medscape, Drug & Disease, Quercetin (Herbs/Suppl.), http://reference.medscape.com/drug/quercetin-344495#3 (Accessed September 16, 2015).

Medscape, Drug & Disease, Quercetin (Herbs/Suppl.), http://reference.medscape.com/drug/quercetin-344495#2 (Accessed September 16, 2015).